|
Imagine yourself sitting in a classroom--say, a fourth-grade social-studies
class. There is a teacher at the front of the room, but a groundskeeper mowing
grass outside captures your attention instead. When the mower moves away,
however, you feel bored and restless. Pretty soon your swinging feet slam into
the seat in front of you. The attentive student sitting there yelps and the
teacher interrupts the class to ask what the problem is. This sudden activity
jolts you back into focus; at least something interesting is happening. You're
beyond feeling embarrassed about being the center of this kind of attention. It
happens all the time, and you have quite a reputation for this sort of thing.
And besides, it isn't really your fault. They all say you probably have ADD or
ADHD or something like that and can't help but act this way. It's just the way
life is for some kids.
Scenes like this one, with endless variations, are played out across the United
States every day in classrooms, on playgrounds, and in homes. The American
Psychiatric Association's (APA's) Diagnostic and Statistical Manual, Version IV (DSM-IV), says that when a pattern of such behavior persists for six months or
longer, and occurs in at least two different settings (e.g., in the classroom
and at home), it may meet the criteria for a diagnosis of
Attention-Deficit/Hyperactivity Disorder (ADHD). The combination of attention
deficit and hyperactivity is common, but either can, and often does, occur
without the other. Boys are between five and nine times as likely to be
diagnosed with ADHD as girls, although many researchers are now suggesting that
there may be many more girls who have an attention deficit but aren't diagnosed
because they aren't hyperactive or impulsive and so don't cause the kinds of
problems that lead to parental or teacher intervention. And ADHD is no longer
associated with just middle childhood; it is being diagnosed with increasing
frequency in teenagers, adults, and even preschoolers.
What, exactly, is ADHD? The APA considers it a mental disorder, which it
defines as a pattern of thought and behavior associated with distress and
impairment of functioning resulting from some dysfunction within the
individual. In the case of ADHD, the most quickly noticed behavioral and
psychological patterns are the hyperactivity and inattentiveness described
above. Such children typically don't finish their homework, can't complete
class assignments or exams in the time allowed, and are generally disorganized
and forgetful. About one in five, most often those with a diagnosis of
impulsivity or hyperactivity, tends to be socially inept and isolated due to an
inability to understand or follow the rules that govern civil human
interaction. The adult version of the disorder shows the same patterns,
rescaled to the tasks and settings of the grown-up world.
At first glance, these behavioral patterns seem to count as impairments of
functioning. If that is so, then it isn't a big step to conclude that some
intervention is warranted. But the ADHD diagnosis has become highly
controversial in recent years, with much of the controversy focused around the
increasing use of the drug methylphenidate hydrochloride, an amphetamine, more
popularly known by its trade name "Ritalin," as the treatment of choice.
Although Ritalin is sometimes used for the treatment of other conditions, ADHD
accounts for the overwhelming majority of prescriptions for it, and these have
proliferated since 1990. Figures published in the August 12, 1996, issue of
Forbes magazine show a fourfold increase in the rate of methylphenidate
consumption between 1989 and 1994, a rise so dramatic that the U.S. Drug
Enforcement Agency asked the United Nations' International Narcotics Control
Board to look into the situation. The United Nations released a report in
February of 1996 expressing concern over the discovery that 10 percent to 12
percent of all male school children in the United States currently take the
drug, a rate far surpassing that in any other country in the world. Indeed,
citizens of the United States, most of them well below the legal drinking or
smoking age, now consume over 90 percent of the 8.5 tons of methylphenidate
produced worldwide each year.
There is something odd, if not downright ironic, about the picture of millions
of American school children filing out of "drug-awareness" classes to line up
in the school nurse's office for their midday dose of amphetamine. It is this
sort of image that fires the imaginations of Ritalin's critics--critics like
child psychiatrist Carl L. Kline of the University of British Columbia who was
reported in the August 4, 1991, New York Times Education Supplement as saying
that Ritalin is nothing more than a street drug being administered to cover the
fact that we don't know what's going on with these children.
Proponents, on the other hand, include many parents like Jane Leavy, who wrote
an impassioned defense of the drug's use for the March 18, 1996, issue of
Newsweek. She documents dramatic improvements in her son's academic and social
performance thanks to Ritalin. Similar testimonials can be found in the growing
number of ADHD discussions on the internet. These parents are staunch defenders
of Ritalin--this miraculous drug has relieved their children of debilitating
stress and unhappiness, they say. Indeed, a temporary shortage of Ritalin, in
1993, following the government's failure to give timely approval to Ciba
Pharmaceuticals (Ritalin's manufacturer) to increase production, led to a
widely reported public outcry and weeks of high anxiety among parents who
feared being without the little yellow pill. For these people, the child's trip
to the nurse's office is far from ironic; it is a pilgrimage in honor of one of
the great successes of modern psychopharmacology.
Discovering which view represents the better understanding of Ritalin and the
condition it is intended to treat is not quite as simple as talk-show
discussions and magazine articles sometimes make it seem. The difficulties
begin with the fact that no one really understands the etiology of ADHD.
Environmental factors from lead to sugar and food additives have been blamed,
but there is no clear empirical support for such claims. Nor have investigators
been able to explain the disorder by appeal to parenting styles or other
socialization factors. Instead, what has emerged in recent years is mounting
evidence that the problem runs in families. Among monozygotic (genetically
identical) twins, when one twin is diagnosed with ADHD the other also receives
the diagnosis 51 percent of the time. In contrast, among dizygotic twins, no
more related to each other genetically than ordinary siblings, the concordance
rate is only 33 percent. Combined with the fact that adoption studies show that
the relationship runs more strongly in genetic families than in the family of
upbringing, these data suggest that there is a genetic contribution to whatever
is going on in ADHD.
This does not mean, however, that ADHD is genetically determined. If it were,
then the concordance rate for monozygotic twins would be 100 percent, as it is
for eye color. Rather, it means that there may be something in the genetic
blueprint for wiring up the brains of some people which disposes them to the
pattern of thought and action that gets labeled ADHD. At best, however, this is
but a small part of the story, for it does not tell us what kinds of
experiences in the world act together with this genetic disposition to produce
the ADHD pattern. Most researchers are now convinced that there is no single
answer to that question; it seems increasingly likely that there are many
different paths to the syndrome. That makes it difficult to offer simple
prescriptions for preventing the ADHD pattern from developing. The best the
psychiatric community has to offer is treatment once ADHD does develop, and, at
the moment, the most popular treatments involve stimulant drugs like Ritalin.
Interestingly, the effectiveness of Ritalin and similar stimulants in changing
the behavior of ADHD children has led researchers to think that they know what
is different about the brains of those afflicted with ADHD. One of the most
systematic attempts to piece together this puzzle has been made by James
McCracken, professor of psychiatry at UCLA and his colleagues Steven Pliszka
and James Maas, both professors of psychiatry at the University of Texas Health
Science Center in San Antonio. Writing in the March 1996 issue of the Journal
of the American Academy of Child and Adolescent Psychiatry, they proposed what
is known in the community of ADHD researchers as the "catecholamine hypothesis"
to explain what is wrong in the brains of people with attentional dysfunction.
It's worth spending a little time trying to understand this theory because
knowing just what is going on in ADHD patients helps to clarify what is really
at stake in the controversy over Ritalin.
The catecholamines referred to in the phrase "catecholamine hypothesis" are
among the dozens of special chemicals in the brain, known as neurotransmitters,
that make it possible for the millions of nerve cells that make up that organ
to communicate with each other. When a nerve cell "fires," it releases tiny
amounts of these chemicals into the small gaps, called synapses, that separate
it from the cells to which it sends connections. These chemicals diffuse across
the gap and attach themselves to special receptors on the receiving cell. Upon
attaching, they change the chemical balance inside the receiving cell, making
it more or less likely to fire in its own turn. All of the activities of the
mind, including those that make it possible for you to read these sentences,
are the result of quadrillions of such events taking place every second in the
brain.
But these electrochemical processes must occur at the right levels of intensity
and in the right patterns for the mind to function effectively. Too much of a
neurotransmitter, or too little, being released in various parts of the brain
can lead to a variety of disorders. For example, a deficit of a
neurotransmitter called dopamine, one of the main classes of catecholamines,
means that it can't send the right messages to control the contractions in the
body's muscles, and one sees, as a result, the tremors of Parkinson's disease.
Pliszka, McCracken, and Maas have proposed that ADHD is such a neurotransmitter
dysfunction, in this case a catecholamine imbalance. The catecholamines are
used by many different circuits in the brain, but these researchers suggest
that when there is an imbalance in the circuits that control attention, some
form of ADHD is the result. Although these are among the most complex systems
in all of nature, the basic logic of their hypothesis is simple enough.
Controlling attention means that one has to be able to do two things. On the
one hand, one has to be able to stay focused on a task or activity in the face
of unavoidable distractions from the world outside and from one's own thoughts
and sensations. But there has to be a way to disengage and then shift attention
to a different activity if the need arises. A person's being too focused and
unable to disengage can be just as much a problem as his not being able to stay
focused in the first place. A balance must be struck, and that's what the
attention circuits are supposed to do.
But what is the right balance? The answer is, and this is the most important
point, the right balance must be appropriate to the kinds of tasks and
situations one encounters. The balance is likely to be different for someone
trading commodities in the pit of the Chicago Mercantile Exchange, a surgeon
performing a delicate operation in a hospital, or a parent trying to cook
dinner and keep an eye on the baby at the same time. And the precise nature of
that balance is related in a complex way to the balance of the catecholamines
in the attention circuits.
Stimulant drugs such as Ritalin affect that balance by increasing the amount of
time that catecholamine molecules remain active in certain synapses. Exactly
where the balance is reset is still unclear and may vary from one person to the
next. The complex neurophysiology of these circuits may also help to explain
why many school-age children, and even more preschoolers and adults, don't seem
to respond positively to methylphenidate but do respond to other stimulants
like dextroamphetamine. These drugs are very similar in their effects, but the
differences can be important in a circuit this complex. About 70 percent of the
children diagnosed with ADHD will respond to one of the amphetamines, most of
them to Ritalin. Of the remaining 30 percent, at least one-half will show
improvement when they are given one of a class of anti-depressant drugs also
known to affect the catecholamine neurotransmitters. And some children do not
respond to any of these drug therapies.
So far there is no way to know before the fact which drugs, if any, will be
useful for a given child. Only trial and error reveals which drug treatment
will improve the troublesome pattern of behavior. And that suggests that the
diagnostic criteria for establishing the presence of ADHD are incomplete.
Indeed, although many physicians use the drug as a diagnostic tool--in other
words, if Ritalin seems to improve attention, the patient is assumed to have
ADHD--an improvement in attentional control after taking a drug like Ritalin
does not, in fact, establish the diagnosis of ADHD. Studies conducted during
the mid seventies to early eighties by Judith Rapaport of the National
Institutes of Mental Health clearly showed that stimulant drugs improve the
performance of most people, regardless of whether they have a diagnosis of
ADHD, on tasks requiring good attention. Indeed, this probably explains the
high levels of "self-medication" around the world (stimulants like caffeine and
nicotine, for example). Particularly interesting is the fact that cocaine,
still reputed to be the illegal drug of choice in the world of the young,
upwardly mobile, and highly focused crowd, has a psychopharmacology that is
very similar to that of methylphenidate. In short, even if you have never been
diagnosed as having a problem paying attention, many of these drugs will
improve your focus and performance. The fact that a child is more attentive
while taking Ritalin doesn't then mean that he has a documentable mental
disorder.
So how is it decided that a child, or adult, should be considered attentionally
disordered? The answer has varied over the last 40 years. In 1957, the first
APA Diagnostic and Statistical Manual contained no mention of any disorder
remotely like ADHD. By 1968, however, when DSM-II was published, there was a
new diagnostic category known as "hyperkinetic reaction of childhood." The use
of the term "reaction" here is significant, because the APA makes a distinction
between a disorder and a reaction, the latter suggesting a milder, possibly
less chronic condition. It wasn't until the appearance of DSM-III, in 1980,
that attention deficit disorder or ADD was recognized. At that time, a
distinction was made between ADD with hyperactivity (ADD/H) and without
(ADD/WO). By 1987, the APA found it necessary to revise its manual again, and,
in DSM-III-R (for revised), it was decided that there was a single dimension of
disorder known by the now-familiar ADHD designation. However, by the time of
the 1994 publication of DSM-IV, diagnosticians were convinced that the earlier
DSM-III distinctions had been closer to the mark, and they proposed the current
classification system with its three sub-types (with hyperactivity only, with
inattention only, and the combined form).
Why has it been so difficult to stabilize the diagnostic criteria for ADHD?
There are several possible answers. One of them is that the disorder itself is
subtle and difficult to detect in all but extreme cases. This explanation is
similar to ones that physicians offer when challenged to defend the diagnosis
of chronic fatigue syndrome, a medical condition that, like ADHD, wasn't even
in the diagnostician's toolbox a few decades ago. One who wanted to defend the
diagnosis could argue that the disorders were known, at least in extreme cases,
but that there were other, more folk-psychological explanations for these
patterns which prevented people from seeing them as true disorders. People with
chronic fatigue syndrome were simply thought to be "malingering." And children
with ADHD were thought to be either "slow," if the problem was inattention, or
"wild," if the problem was impulsivity. The shift to viewing ADHD as a mental
disorder could be seen, from this vantage, as an enlightened move.
But there is another reason why the criteria for ADHD might have been so
difficult to articulate, and it calls into question the very foundation of the
APA's diagnostic system. The APA has made the decision to formulate its
diagnoses as categories of disorder. This means that one either does or does
not have ADHD, or obsessive-compulsive disorder, or conduct disorder, or
what-have-you. The alternative would be to focus on dimensions of difference.
Our growing understanding of how we pay attention makes it clear that
attentional capacities are measurable on dimensions of persistence,
distractibility, impulsivity, flexibility, and control. These different factors
define a multi-dimensional space of possibilities for how we pay attention, and
each of us occupies a unique region in that space.
From this perspective, diagnosing a child as having an attentional disorder
seems to require drawing lines along the various continua and deciding that
people on one side are normal and those on the other are not. Somewhere between
the person with exquisite control over the focus of his attention and the
befuddled scatterbrain, we judge the attention-control system to be broken and
in need of treatment.
But how are we to decide which side of the line a given person is on? There
are, as it turns out, two answers to this question. One is the official answer,
and the other reflects what actually happens in the offices of school
psychologists and pediatricians.
Officially, experts make very specific and stringent recommendations about how
to correctly diagnose ADHD. Dennis Cantwell, in a recent review of the last
decade of research on ADHD for the August 1996 issue of the Journal of the
American Academy of Child and Adolescent Psychiatry, summarizes the current
recommendations. The diagnosis should begin with thorough interviews of anyone
who acts as parent to the child. The goal is to establish, in detail, under
what circumstances the presenting symptoms occur and to take a complete
developmental, medical, and family history. Following these interviews, the
clinician should interview the child in order to elicit his view of the
problem. This interview should include screening for other problems that might
be the real source of difficulty, including other mental disorders (depression,
anxiety, hallucinations, etc.). The child should also be given a thorough
medical examination to rule out neurological or sensory problems (poor hearing
or eyesight, for example) as the cause of symptoms. The child should then be
given tests of intelligence and achievement, and the clinician should evaluate
questionnaires filled out by both parents and teachers. These questionnaires
ask the respondent to indicate the degree to which the child displays the
patterns of behavior that are considered markers for ADHD. Further tests may be
required to rule out possible problems that emerge during this lengthy
examination.
In reality, few physicians report anything like this level of scrutiny before
prescribing treatment. In a recent survey of pediatricians, published in the
Archives of Pediatric and Adolescent Medicine, nearly 50 percent of doctors
confess to spending an hour or less with a child before making a diagnosis and
prescribing medication (usually Ritalin). Obviously, the thorough regimen of
examinations suggested by the experts can't be performed in such a short period
of time. What should make this particularly worrisome, even for those who are
willing to defend the current criteria for diagnosing ADHD, are recent findings
by Mark Wolraich and his colleagues at the Vanderbilt University Child
Development Center that as many as two-thirds of all children who meet the
DSM-IV criteria for ADHD have other problems as well. These are referred to in
the psychiatric community as "comorbid conditions," and they most often include
things like anxiety and so-called conduct disorders. This is particularly
significant information to have when prescribing medications, because stimulant
drugs actually may be counterproductive for children with certain of these
problems. Combine this with the finding by Linda Copeland and her colleagues,
reported in 1987 in Developmental and Behavioral Pediatrics, that most
pediatricians do not adequately monitor the medications of their ADHD patients
once they have prescribed them and you have a troubling situation indeed.
If diagnoses and follow-ups are not being conducted by experts' examinations,
then how are they being made? The research literature suggests that it is
behavioral ratings of teachers and parents which are most often used to assign
the ADHD classification. The parent or teacher is presented with a number of
statements such as, "Is easily distracted by extraneous stimuli," and is asked
to indicate the degree to which this statement applies to the child. Responses
to all of the questions are summed, and the result is compared to established
norms. If the child falls outside this normative range, he receives the ADHD
diagnosis. In other words, a line is drawn beyond which an individual
difference is labeled a pathology.
The problem, of course, is that the decision about where to draw that line is a
judgment call. Wolraich and his colleagues applied the criteria for ADHD from
both DSM-III-R and DSM-IV to the same sample of 8,258 children and found that
7.3 percent of them have ADHD according to DSM-III-R, while more than half
again as many, 11.4 percent, qualify using DSM-IV criteria. Even using the same
rating scales yields different percentages depending on the standard one uses.
If a teacher has to say that various characteristics, like distractibility or
forgetfulness, very much describe a child before ADHD is diagnosed, the
proportion of ADHD children may run as low as 4 percent. But if the teacher can
say either that the traits are very much characteristic of the child or only
pretty much so, the proportion rises to over 18 percent.
So this is the situation in which we find ourselves. The psychiatric community
has decided to collapse a complex, multidimensional pattern of behavior into
two categories. One it considers normal; the other it considers pathological
(with three variations) and labels ADHD. Meanwhile, treating physicians have
collapsed a thorough diagnosis regime into a one-hour visit. As a result,
diagnosis and treatment outside the research laboratory vary widely: The number
of grams of Ritalin used per 100 population ranges from a low of 0.25 grams in
Hawaii to a high of 2.36 grams in Georgia, a nearly tenfold difference.
Nevertheless, taking the country as a whole, we learn that the overall trend is
toward increasing use of the label ADHD for school-age children and its gradual
extension to cover adults and pre-schoolers as well. And this growth in the
number of diagnosed cases is accompanied by a dramatic increase in the last
decade in the use of certain stimulant drugs to treat the symptoms of the
disorder.
What remains unclear is why there should be an increase in the use of the
diagnosis. After all, the flexibility of the criteria for considering a child
to have ADHD could just as well have been used to decrease the number of
children so diagnosed. Why have the numbers gone up?
There is no existing research to answer this question definitively. The
research suggests that changes in the DSM criteria may have had an effect on
the overall numbers of children who are considered to have ADHD, but that
doesn't explain why the percentages of children who are diagnosed and put on
medication vary from one part of the country to another. The best we can do in
response to this question is to propose hypotheses for future research. To do
that, however, it helps to have a few additional facts about the typical
sequence of events leading up to a diagnosis of ADHD.
The precipitating events almost always take place at school. It is no accident
that the disorder was long considered to be a problem that did not arise until
about the age of five. The growth in the number of children attending nursery
schools, beginning at age three or four, probably then accounts for the recent
rise in diagnoses of the disorder at these younger ages. What this means is
that the first suggestion that a child might have ADHD is usually made by a
teacher, often during a parent-teacher conference, and not by a parent. The
teacher already may have asked the school psychologist to observe the child and
filled out one of the teacher rating forms for assessing attention and
impulsivity. The teacher may then suggest an evaluation by the family's
pediatrician or some other specialist.
Once this formal evaluation begins, as we have seen, the process can move with
great rapidity. A few minutes with the child, some discussion with a concerned
parent, and perhaps a look at the teacher's rating forms and a report from the
school psychologist, and the doctor makes a diagnosis of ADHD. Medication is
prescribed, most often Ritalin initially, and the child officially joins the
ranks of the attentionally impaired.
But why of late are more teachers making such referrals? The most innocent
explanation is that as teachers, and to some degree parents as well, have
become better educated about this problem, they have tended to seek
professional help when signs of ADHD are first detected. Indeed, there is a
trend underway toward making the school an extension of the therapy
establishment. For example, school psychologists have been very active
proponents of the need for increased mental-health services for school
children. Beth Doll, of the University of Colorado at Denver, writing in the
Winter 1996 issue of the School Psychology Quarterly, urges the establishment
of training programs that would "create therapeutic schools in which ownership
for students' mental health is fostered among every teacher and administrator
in a building." This is newspeak for the idea that teachers and administrators
have to be taught how to think and act as therapists as well as educators. This
vision of the school as a mental-health facility may already be affecting how
teachers and school psychologists view their roles in the system, with the rise
in the number of children with the ADHD diagnosis as a kind of lagging
indicator of these changes.
Not everyone in the school system, however, seems eager to embrace the
therapeutic model of the school. Cost-conscious school administrators and
school boards are leery of this new focus on mental health. And they cringe
every time another student is added to the ADHD population in a school, for
many parents are being informed by physicians who diagnose their children that
ADHD counts legally as a disability and therefore qualifies the child for
special treatment under the Americans with Disabilities Act. By this law, the
school system is obligated to provide "equal access" to the curriculum for such
children, which may mean paying for special remedial services or other
therapies. Given a fixed school budget, the funds for such services have to
come out of other programs, with net negative results for other students in the
school. So from the standpoint of school administrators, there is a financial
disincentive to ADHD diagnoses.
However, it may turn out that state departments of education and local school
boards are finding themselves nonetheless hoist with their own petard. It may
prove significant that the rise in the number of referrals for ADHD tracks the
adoption throughout the country of outcome-based educational goals.
Outcome-based systems are predicated on the idea that every child can and
should be brought to some high minimal standard of performance in the
curriculum. These systems are motivated philosophically by an egalitarian view
of society; we are all entitled, on this view, to an equally effective
education at the public's expense.
But once you have adopted such a system, teachers cannot respond to
uncooperative and inattentive students by simply passing them on to the next
grade. Outcome-based programs make the teacher directly accountable for the
child's performance. Teachers now become desperate seekers after anything that
will enable them to improve the child's performance to the mandated level.
Hence their eagerness to suggest the quick fix of drug therapy if the child's
problem seems attentional.
It would require careful and elaborate research to test this hypothesis
thoroughly, but a crude check of its plausibility can be made by comparing the
rate of Ritalin consumption in the 50 states and District of Columbia with data
from the U.S. Census on whether or not the state has some sort of exit exam or
competency requirement for graduation from high school. The latter data are
crude, require some interpretation, and are not quite as contemporary as the
data for Ritalin consumption; so the result must be viewed as very tentative.
But it is interesting that states with competency or exit requirements have
higher levels of Ritalin consumption than states that do not, on average. The
difference is not large, amounting on average to only about .3 grams per 100
population, but it is statistically significant. This means that it is at least
possible that the pressure to get students to perform to high levels in the
public-school classroom is leading teachers to promote the ADHD diagnosis and
subsequent treatment with a drug that improves the child's behavior.
Indeed, the data on how Ritalin affects performance are consistent with this
view. The child for whom Ritalin (or one of the other drugs) works tends to
remain "on task" longer and, therefore, tends to complete more work. This
includes work on exams and homework assignments, with the result that the
child's grades may actually show improvement. The child tends to become more
cooperative, to follow directions better, and thus to get along better with
other children and with the teacher. This has the beneficial side effect of
improving the classroom environment by reducing disruptions and time away from
other students, and so increases the teacher's effectiveness with the class as
a whole.
What Ritalin does not do, and this is a finding about which proponents of the
ADHD diagnosis tend to be defensive, is to improve long-term achievement-test
scores. The drug simply makes the child more manageable and better able to work
to the level of the system's expectations. It does not seem to produce
long-term changes in cognitive functioning.
It is tempting to view this pattern as suggesting that the ADHD diagnosis
provides teachers with a new technique for regaining control of the classroom
in a world where many of the traditional methods of control have been
eliminated. Drugs have replaced the reprimand.
But it seems to me that the real problem may be that the concept of compulsory,
cookie-cutter education needs rethinking. In spite of the rhetoric in schools
of education about the importance of taking into account the individual needs
of the children in a classroom, the current system of public education is
designed to make that nearly impossible. State curriculum guidelines and
requirements, coupled with further requirements from the local community,
prevent teachers from making any serious effort to tailor materials and
assignments to the differing abilities and dispositions of individual children.
Nor is there any mechanism, of the sort one would find in a school-choice-based
system of education, for parents to seek out schools tailored to the
temperaments and capabilities of their children. Instead, it becomes necessary
to find ways of making children able to perform in the environment as they find
it. And, in late twentieth-century America, when it is difficult or
inconvenient to change the environment, we don't think twice about changing the
brain of the person who has to live in it. The rise in consumption of Ritalin
is only one manifestation of this cultural practice. Consider Prozac or, in
previous decades, Valium.
None of this should be taken to suggest that there are no cases of genuine
brain damage or dysfunction that require medical intervention. There have
always been diseases of the brain, as of any other organ, and they should be
treated as such. But difference does not automatically equal disease. Is
changing the child's brain chemistry, by prescribing Ritalin-like drugs, really
the most appropriate response to the child who doesn't perform well in the
modern school environment? Perhaps it's time we asked ourselves whether the
fact that so many children can't learn well in our schools is a reflection on
the schools, not the children.
home · watch the program · four families · adhd drugs · adhd · backlash
readings · adhd in schools · interviews · discussion · the producers · viewers' guide
synopsis · tapes & transcripts · press reaction · credits
frontline · wgbh · pbs online
pill photograph copyright ©2001 photodisc all rights reserved
web site copyright WGBH educational foundation
|